Is OM or STXS more undervalued in 2026?

CirclFi compares Outset Medical, Inc. (OM) and Stereotaxis, Inc. (STXS) using 13 institutional-grade valuation models. OM has a Quality of Company score of 6.7/10 while STXS scores 6.0/10.

Which is a better buy — OM or STXS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OM and STXS valuations compare?

OM at $4.89 and STXS at $1.98 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OM vs STXS Valuation Comparison 2026 — Intrinsic Value Analysis

OM

Electromedical & Electrotherapeutic Apparatus

Outset Medical, Inc.

Quality

6.7

out of 10

Value Trap

SAFE

Price

$4.89

Last close

Models

10/13

Active

STXS

Electromedical & Electrotherapeutic Apparatus

Stereotaxis, Inc.

Quality

6.0

out of 10

Value Trap

LOW

Price

$1.98

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	OM Fair Value	OM Upside	STXS Fair Value	STXS Upside
Bayesian DCF	Intrinsic	—	—	$0.47	-76.1%
Earnings Power Value	Intrinsic	$5.29	+21.3%	$0.74	-61.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$6.30	+28.9%	$0.12	-94.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OM vs STXS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OM vs STXS — Which Stock Is More Undervalued?

OM scores higher with a 6.7/10 quality rating vs STXS's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Outset Medical, Inc. (OM) and Stereotaxis, Inc. (STXS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OM currently trades at $4.89 with a QOC of 6.7/10, while STXS trades at $1.98 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).